
Narval
We use Artificial Intelligence to design synthetic Antibody Mimetic Proteins to replace conventional antibodies in novel first-in-class therapeutics.
Details
-
Founded Date
2023
-
Industries
HealthTech, Healthcare Biotech AI/Machine Learning
-
Operating Status
Open
Currently Raising - Website
Founders
-
Jose Luis Nuno
Founder